Use of wearable cardioverter‐defibrillator in association with catheter ablation for atrial fibrillation‐related tachycardiomyopathy

Implantable cardioverter‐defibrillator (ICD) is an effective therapy in patients known to be at high risk for sudden cardiac death (SCD). Nevertheless, ICD implantation is not indicated in transient or reversible causes of SCD. Wearable cardioverter‐defibrillator is increasingly used for SCD prevent...

Descripción completa

Detalles Bibliográficos
Autores principales: Conti, Sergio, Bonomo, Vito, Taormina, Antonio, Giordano, Umberto, Sgarito, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510012/
https://www.ncbi.nlm.nih.gov/pubmed/31110733
http://dx.doi.org/10.1002/ccr3.2089
_version_ 1783417366328115200
author Conti, Sergio
Bonomo, Vito
Taormina, Antonio
Giordano, Umberto
Sgarito, Giuseppe
author_facet Conti, Sergio
Bonomo, Vito
Taormina, Antonio
Giordano, Umberto
Sgarito, Giuseppe
author_sort Conti, Sergio
collection PubMed
description Implantable cardioverter‐defibrillator (ICD) is an effective therapy in patients known to be at high risk for sudden cardiac death (SCD). Nevertheless, ICD implantation is not indicated in transient or reversible causes of SCD. Wearable cardioverter‐defibrillator is increasingly used for SCD prevention in patients with a transient risk of ventricular arrhythmia.
format Online
Article
Text
id pubmed-6510012
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65100122019-05-20 Use of wearable cardioverter‐defibrillator in association with catheter ablation for atrial fibrillation‐related tachycardiomyopathy Conti, Sergio Bonomo, Vito Taormina, Antonio Giordano, Umberto Sgarito, Giuseppe Clin Case Rep Case Reports Implantable cardioverter‐defibrillator (ICD) is an effective therapy in patients known to be at high risk for sudden cardiac death (SCD). Nevertheless, ICD implantation is not indicated in transient or reversible causes of SCD. Wearable cardioverter‐defibrillator is increasingly used for SCD prevention in patients with a transient risk of ventricular arrhythmia. John Wiley and Sons Inc. 2019-04-10 /pmc/articles/PMC6510012/ /pubmed/31110733 http://dx.doi.org/10.1002/ccr3.2089 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Conti, Sergio
Bonomo, Vito
Taormina, Antonio
Giordano, Umberto
Sgarito, Giuseppe
Use of wearable cardioverter‐defibrillator in association with catheter ablation for atrial fibrillation‐related tachycardiomyopathy
title Use of wearable cardioverter‐defibrillator in association with catheter ablation for atrial fibrillation‐related tachycardiomyopathy
title_full Use of wearable cardioverter‐defibrillator in association with catheter ablation for atrial fibrillation‐related tachycardiomyopathy
title_fullStr Use of wearable cardioverter‐defibrillator in association with catheter ablation for atrial fibrillation‐related tachycardiomyopathy
title_full_unstemmed Use of wearable cardioverter‐defibrillator in association with catheter ablation for atrial fibrillation‐related tachycardiomyopathy
title_short Use of wearable cardioverter‐defibrillator in association with catheter ablation for atrial fibrillation‐related tachycardiomyopathy
title_sort use of wearable cardioverter‐defibrillator in association with catheter ablation for atrial fibrillation‐related tachycardiomyopathy
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510012/
https://www.ncbi.nlm.nih.gov/pubmed/31110733
http://dx.doi.org/10.1002/ccr3.2089
work_keys_str_mv AT contisergio useofwearablecardioverterdefibrillatorinassociationwithcatheterablationforatrialfibrillationrelatedtachycardiomyopathy
AT bonomovito useofwearablecardioverterdefibrillatorinassociationwithcatheterablationforatrialfibrillationrelatedtachycardiomyopathy
AT taorminaantonio useofwearablecardioverterdefibrillatorinassociationwithcatheterablationforatrialfibrillationrelatedtachycardiomyopathy
AT giordanoumberto useofwearablecardioverterdefibrillatorinassociationwithcatheterablationforatrialfibrillationrelatedtachycardiomyopathy
AT sgaritogiuseppe useofwearablecardioverterdefibrillatorinassociationwithcatheterablationforatrialfibrillationrelatedtachycardiomyopathy

Ejemplares similares